Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1294649.RA8iXLn2ifdikh-wsJ4DU3vMSnx7HSbIibRVzSiPon7sQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1294649.RA8iXLn2ifdikh-wsJ4DU3vMSnx7HSbIibRVzSiPon7sQ130_assertion type Assertion NP1294649.RA8iXLn2ifdikh-wsJ4DU3vMSnx7HSbIibRVzSiPon7sQ130_head.
- NP1294649.RA8iXLn2ifdikh-wsJ4DU3vMSnx7HSbIibRVzSiPon7sQ130_assertion description "[Patients with higher expression of miR-3151 had shorter overall survival (P=0.0025), shorter leukemia-free survival (P=0.026) and higher cumulative incidence of relapse (P=0.082).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1294649.RA8iXLn2ifdikh-wsJ4DU3vMSnx7HSbIibRVzSiPon7sQ130_provenance.
- NP1294649.RA8iXLn2ifdikh-wsJ4DU3vMSnx7HSbIibRVzSiPon7sQ130_assertion evidence source_evidence_literature NP1294649.RA8iXLn2ifdikh-wsJ4DU3vMSnx7HSbIibRVzSiPon7sQ130_provenance.
- NP1294649.RA8iXLn2ifdikh-wsJ4DU3vMSnx7HSbIibRVzSiPon7sQ130_assertion SIO_000772 26430723 NP1294649.RA8iXLn2ifdikh-wsJ4DU3vMSnx7HSbIibRVzSiPon7sQ130_provenance.
- NP1294649.RA8iXLn2ifdikh-wsJ4DU3vMSnx7HSbIibRVzSiPon7sQ130_assertion wasDerivedFrom befree-2016 NP1294649.RA8iXLn2ifdikh-wsJ4DU3vMSnx7HSbIibRVzSiPon7sQ130_provenance.
- NP1294649.RA8iXLn2ifdikh-wsJ4DU3vMSnx7HSbIibRVzSiPon7sQ130_assertion wasGeneratedBy ECO_0000203 NP1294649.RA8iXLn2ifdikh-wsJ4DU3vMSnx7HSbIibRVzSiPon7sQ130_provenance.